2005
DOI: 10.1021/jm050099q
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Antimuscarinic Properties of Quinuclidin-3-yl 1,2,3,4-Tetrahydroisoquinoline-2-carboxylate Derivatives as Novel Muscarinic Receptor Antagonists

Abstract: In the course of continuing efforts to develop potent and bladder-selective muscarinic M3 receptor antagonists, quinuclidin-3-yl 1-aryl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives and related compounds were designed as conformationally restricted analogues of quinuclidin-3-yl benzhydrylcarbamate (8). Binding assays with rat muscarinic receptor subtypes revealed that the quinuclidin-3-yl 1-aryl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives showed high affinities for the M3 receptor, and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
86
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 141 publications
(86 citation statements)
references
References 28 publications
0
86
0
Order By: Relevance
“…1) and 17 selective hM3 antagonists (Table I) were chosen [17][18][19]. The 2D starting structure of each ligand was drawn with ISIS Draw [20], and was converted to the 3D structure with the ModelBuilder module from the HyperChem7.52 package.…”
Section: Ligand Setupmentioning
confidence: 99%
“…1) and 17 selective hM3 antagonists (Table I) were chosen [17][18][19]. The 2D starting structure of each ligand was drawn with ISIS Draw [20], and was converted to the 3D structure with the ModelBuilder module from the HyperChem7.52 package.…”
Section: Ligand Setupmentioning
confidence: 99%
“…For instance, (R)-3-quinuclidinol is a key chiral intermediate of many drugs such as aclidinium bromide [4], solifenacin succinate [5] and revatropate [6]. Aclidinium and revatropate are anticholinergic for long-term management of chronic obstructive pulmonary disease (COPD) which leads to more than 3 million deaths worldwide every year [7] and is also the third leading cause of death in United States following cancer and heart disease.…”
Section: Introductionmentioning
confidence: 99%
“…1 In particular, (R)-3-quinuclidinyl ester of (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline carboxylic acid (1, solifenacin) is a competitive muscarinic acetylcholine receptor antagonist currently used in the treatment of overactive bladders. 2 On the other hand, N-acetyl-1- (4-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (2) is a potent 2-amino-3- (3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptor antagonist. 3 AMPA receptor antagonists are used as neuroprotective agents in the treatment of neurological diseases such as epilepsy, ischemia, Parkinson's disease, and multiple sclerosis.…”
mentioning
confidence: 99%
“…9 The sulfinyl group is highly stereodirecting and activates the C=N bond effectively in nucleophilic addition reactions, and can easily be removed to provide the enantiopure amine derivatives. 10 Inspired by its versatility in asymmetric synthesis, we attempted the total synthesis of solifenacin (1) and N-acetyl-1-(4-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (2) using N-tert-butanesulfinamide as a source of chirality. Following our interest on the use of (R)-tert-butanesulfinamide for the synthesis of chiral amines, 11 we herein report a simple and efficient synthesis of solifenacin (1), an antispasmodic agent via the addition of aryl Grignard reagent to N-sulfinimine.…”
mentioning
confidence: 99%
See 1 more Smart Citation